Grifols shares tumble

Grifols to Outline Standalone Strategy After Brookfield Drops $6.8 Billion Bid
Grifols said it plans to outline its strategy as a standalone company after Brookfield Asset Management dropped out of talks for a 6.45 billion-euro ($6.82 billion) takeover bid.The Spanish pharmaceutical company said late Wednesday that it would soon schedule an investor update at which it would present its strategy under new leadership and its plans to unlock growth opportunities.
Brookfield Drops $6.8 Billion Offer to Buy Drugmaker Grifols
Brookfield Asset Management Ltd. walked away from a plan to acquire Grifols SA, ending months of negotiations to take over the Spanish blood-plasma company.
Grifols shares tumble after Brookfield drops takeover plan
Canadian fund Brookfield said on Wednesday it has dropped its plan to take over Spain's Grifols due to a disagreement over the pharmaceutical company's value.
Grifols says takeover talks with Brookfield terminated
The board of Spanish plasma-based medicines producer Grifols has announced the termination of discussions with Brookfield Capital Partners (UK) regarding a potential acquisition of Grifols shares.
Brookfield Set to Drop Grifols Bid as Family Shuns Others
Brookfield Asset Management Ltd. is preparing to walk away from a plan to acquire Grifols SA over disagreements on valuation. The Spanish company’s billionaire founding family said it won’t support any new bid to take its namesake drug-maker private.
Grifols slides as Brookfield pulls out of takeover talks
Barcelona-based Grifols has seen its stock value plummet since January when short seller Gotham City Research accused the company of manipulating debt and earnings reporting by consolidating profit from businesses that were sold to a 'vehicle' owned by its founding family.
Grifols shares sink after Brookfield walks away from €6.45bn offer
Brookfield Asset Management has walked away from an acquisition of Spanish healthcare group Grifols after months of negotiations, sending shares in the short seller target down almost 13 per cent.
Grifols Board Announces Termination Of Discussions With Brookfield - Quick Facts
The Board of Directors of Grifols (GRFS) announced the termination of discussions with Brookfield Capital Partners UK regarding a
Brookfield abandons plan for €6.45-billion takeover of drug maker Grifols
Brookfield withdrew its bid for the Spanish pharmaceutical company following a deadlock between the two side over price
Grifols to outline standalone strategy after Brookfield drops €6.45bn bid
The Spanish pharmaceutical company said it considered Brookfield’s offer of 10.50 euros a share undervalued the company and its prospects
Grifols ADRs Tumble After Brookfield Reportedly Backs Away from Takeover Bid
Citing unnamed sources, Bloomberg reported overnight that Brookfield is preparing to drop its 6.45 billion-euro ($6.77 billion) bid to acquire Grifols after failing to reach an agreement with its board on price.
Billionaire Grifols Family Woes in Focus as Brookfield Exits
For Spain’s billionaire Grifols family, which turned a blood-collection business into one of the world’s largest medical ...
Grifols In Talks to Refinance Debt, Credit Line, CEO Says
The embattled Spanish drugmaker Grifols SA is in talks with banks to refinance bonds due next year and extend a revolving ...